Dutch investigators have reported that women who received CMF chemotherapy (a combination regimen including the drugs cyclophosphamide, methotrexate, and 5-fluorouracil) for breast cancer between 1976 and 1995 scored worse ...
4.7 / 5 (3) |
0
|
A study headed up by the Vall d'Hebron Institute of Oncology (VHIO) heralds a new horizon in the fight against cancer, opening up a parallel dimension to existing treatment options. The data, published today in the Journal of ...
5 / 5 (1) |
0
An international team of scientists in Japan, Switzerland, and the United States has confirmed that combining chemotherapy and immunotherapy in cancer treatment enhances the immune system's ability to find and eliminate cancer ...
5 / 5 (1) |
0
(Medical Xpress) -- A University of Kansas researcher has made a discovery that should lead to improved treatments for prostate and breast cancer.
5 / 5 (4) |
0
|
University of Manchester scientists are developing a test that will help identify patients who will benefit from a new breast cancer treatment, thanks to a research grant worth almost £180,000 from Breast Cancer Campaign.
not rated yet |
0
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise. Normally, cells -- even early-stage tumor cells -- are tethered to scaffolding that helps to restrain ...
not rated yet |
0
|
(AP) -- Arline MacCormack first heard about DES from her mother when she was 17. Three decades later, MacCormack believes that the drug her mother took to prevent miscarriages caused her to develop breast ...
not rated yet |
0
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their ...
4.3 / 5 (4) |
1
The US Food and Drug Administration warned a French maker of breast implants now feared to be at risk of rupture of "serious" quality control violations involving saline implants back in 2000.
5 / 5 (1) |
1
The founder of the French firm that made breast implants feared to be at risk of rupturing has admitted using non-approved but non-toxic silicone gels, his lawyer said Tuesday.
not rated yet |
0
Breast implants made by troubled French firm PIP have been at the heart of multiple lawsuits in the United States, where they were sold up until 2000, documents filed with the US government show.
3.4 / 5 (7) |
0
Women who are at risk for breast cancer may also be at greater risk for heart disease, new research has found.
not rated yet |
0
|
(Medical Xpress) -- UCD researchers have identified a novel biomarker that can identify those women with breast cancer who will have a poor response to tamoxifen, one of the principle anti-hormone drugs used ...
not rated yet |
0
Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported today during the CRTC-AACR San Antonio Breast Cancer Symposium.
not rated yet |
0
In a novel therapeutic approach to treating breast cancer, Loyola University Medical Center researchers are reporting positive results from a clinical trial of a drug that targets tumor stem cells.
not rated yet |
0
